30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Voice of Industry

Market Insight: Orthobiologic Products Must Become Procedure-Specific

Orthobiologics play a role in every orthopedic market segment; the importance of their advancements affects the industry as a whole. We asked Andy Carter, Ph.D., Chief Technology Officer at TheraCell, to give his insight on the orthobiologics market—as it stands now, and where it’s heading in the near future. His comments originally appeared in ORTHOWORLD’s Annual Report.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.